UONDDL
AMAG

University of Notre Dame du Lac’s AMAG Pharmaceuticals AMAG Stock Holding History

University of Notre Dame du Lac’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-123,140
Closed -$2.27M – 86
2017
Q2 		$2.27M Buy
123,140
+18,538
+18% +$367K 0.67% 69
2017
Q1 		$2.36M Buy
+104,602
New +$2.5M 0.59% 66

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

University of Notre Dame du Lac's AMAG Position: Q3 2017 in Review

University of Notre Dame du Lac sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 123,140 shares — an estimated $2.27M sold.

University of Notre Dame du Lac first reported a position in AMAG in Q1 2017 and held it in 2 quarters. The position peaked at $2.36M in Q1 2017. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

  • University of Notre Dame du Lac reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • University of Notre Dame du Lac sold 123,140 AMAG Pharmaceuticals shares in Q3 2017, an estimated $2.27M.
  • University of Notre Dame du Lac first reported a position in AMAG Pharmaceuticals in Q1 2017 and held it in 2 quarters.
  • University of Notre Dame du Lac's AMAG Pharmaceuticals position peaked at $2.36M in Q1 2017.
  • 187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on University of Notre Dame du Lac's 13F filing for Q3 2017, filed 13 Nov 2017.